Drug Dosing in Kidney Diseases

5.0(1)
studied byStudied by 2 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/68

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

69 Terms

1
New cards

what qualifies a drug to have no change in regimen for kidney dysfunction patients?

large therapeutic index + fraction excreted unchanged in urine is <= 30% + metabolites are inactive (or no metabolites)

2
New cards

how is absorption changed in patients with kidney dysfunction?

largely unchanged

3
New cards

how is distribution changed in patients with kidney dysfunction?

can be increased, decreased, or unchanged depending on drug (consider protin and tissue binding changes)

4
New cards

how is ametabolism changed in patients with kidney dysfunction?

decreased phase 1 enzyme capacity (CYP450 system), no change in phase II .

5
New cards

how is elimination changed in patients with kidney dysfunction?

decreased kidney elimination

6
New cards

what are some pharmacodynamic changes faced by patients with kidney dysfunction?

increased BBB permeability which increases CNS effects, and decreased platelet aggregation which increases bleed risk

7
New cards

clinical pearls for dosing morphine in kidney dysfunction:

use cation in CKD, avoid in kidney failure due to accumulation of active/toxic metabolite

8
New cards

clinical pearls for dosing codeine in kidney dysfunction:

case reports of narcosis, respiratory failure; avoid or use low doses in renal failure

9
New cards

clinical pearls for dosing hydrocodone in kidney dysfunction:

reduce dose and/or extend interval; accumulation of active/toxic metabolite

10
New cards

clinical pearls for dosing oxycodone in kidney dysfunction:

reduce dose and/or extend interval

11
New cards

clinical pearls for dosing fentanyl in kidney dysfunction:

drug of choice, 25-50% reduction in starting dose

12
New cards

clinical pearls for dosing hydromorphone in kidney dysfunction:

drug of choice, 25% reduction in starting dose

13
New cards

clinical pearls for dosing methadone in kidney dysfunction:

reduce starting dose by 50%

14
New cards

clinical pearls for dosing meperidine in kidney dysfunction:

AVOID - accumulation of neurotoxic metabolites

15
New cards

how does renal dysfunction affect elimination?

decreased GFR, decreased protein binding (increased Fu), and alterations in reabsorption and secretion processes (drug transporters)

16
New cards

what factor most affects loading dose?

Vd

17
New cards

T/F: in general LD for kidney dysfunction equals the LD for normal kidney function

true

18
New cards

what are some drug exceptions to loading dose of kidney dysfunction patients = normal kidney function LD?

digoxin (Vd is reduced in kidney failure therefore the LD if decreased by ~50%), and hydrophilic antibiotics may require higher loading doses in volume overload/AKI (aminoglycosides, beta lactams, carbenems, glycopeptides, linezolid, and colistin)

19
New cards

what factor most affects maintenance dose?

Clearance

20
New cards

which antimicrobial agents DO NOT require dose adjustments for kidney dysfunction?

Azithromycin, Ceftriaxone, Clindamycin, Doxycycline, Linezolid, Metronidazole, and Moxifloxacin

21
New cards

clinical pearls of antibiotics in kidney dysfunction

dose adjustments are dependent upon multiple factors (site of infection/antimicrobial tissue penetration, severity of illness, stability of renal function, and high risk of efficacy failure) and volume of distribution is usually the same or higher in CKD/AKI (LD should not be reduced and consider 24-48 hours of aggressive dosing of antibiotics in AKI)

22
New cards

how does kidney dysfunction affect anticoagulant use

reduced kidney elimination and increased bleed risk

23
New cards

why do kidney dysfunction patients have a higher bleed risk on anticoagulants?

kidney disease causes uremia which leads to platelet dysfunction and ultimately bleeding

24
New cards

which anticoagulant has the lowest percent of kidney clearance?

apixaban

25
New cards

brand of apixaban

Eliquis

26
New cards

brand of rivaroxaban

Xarelto

27
New cards

brand of edoxaban

Savaysa

28
New cards

brand of dabigatran

Pradaxa

29
New cards

afib dosing of apixaban

if SCr >= 1.5 mg/dL and age >= 80 years or BW <= 60 kg —→ Max 2.5mg BID

30
New cards

ESRD dosing of apixaban

5 mg BID or 2.5 mg BID if aged >=8 80 years or BW <= 60 kg

31
New cards

when is rivaroxaban contraindicated ?

CrCl < 15 mL/min

32
New cards

Afib dosing of rivaroxaban if CrCl 15 - 50ml/min

15 mg once daily

33
New cards

when is edoxaban CI?

if CrCl > 95 ml/min

34
New cards

dosing of edoxaban for CrCl 15-50 ml/min?

30 mg once daily

35
New cards

dabigatran dosing for CrCl 30-50 ml/min

75 mg BID

36
New cards

dabigatran dosing for CrCl 15-30 ml/min

75 mg BID (if also on Pgp inhibitor AVOID use)

37
New cards

when is dabigatran CI?

CrCl < 15 ml/min

38
New cards

renal dose adjustments for fondaparinux if CrCl 30-50 ml/min

50% reduction

39
New cards

when is fondaparinux CI?

CrCl < 30 ml/min

40
New cards

T/F: you should avoid enoxaparin use in dialysis patients

true

41
New cards

desirudin dosing when CrCl is 30-60 ml/min/1.73m2

5 mg Q12H

42
New cards

desurudin dosing when CrCl < 30 ml/min/1.73m2

1.7 mg Q12H

43
New cards

renal adjustments for dalteparin

CrCl < 30 ml/min use with caution and monitor anti-Xa levels

44
New cards

renal adjustments for bivalirudin when CrCl is 10-30 ml/min

reduce infusion to 1 mg/kg/hr

45
New cards

dialysis renal adjustments for bivalirudin

reduce infusion to 0.25 mg/kg/hr

46
New cards

when to avoid tinzaparin

CrCl < 30 ml/min

47
New cards

how does Vd change with edematous states?

increases

48
New cards

how does Vd change with muscle wasting/volume depletion?

decreases

49
New cards

what changes in distribution occur in kidney dysfunction?

hypoalbuminemia which leads to decreased protein binding and increased free fraction of drug which leads to toxicity, accumulation of endogenous (BUN) or exogenous (drug metabolites) inhibitors of binding, altered tissue binding

50
New cards

what eGFR is CI for metformin due to increased risk of lactic acidosis?

< 30 ml/min/1.73m2

51
New cards

renal dysfunction considerations for metformin if eGFR is 30-45?

consider 50% dose reduction

52
New cards

renal dysfunction considerations for metformin if eGFR is > 45?

no adjustments

53
New cards

which sulfonylurea is preferred in renal dysfunction?

glipizide

54
New cards

what are the risks associated with sulfonylureas in renal dysfunction?

risk of prolonged hypoglycemia with long duration agents

55
New cards

sitagliptin dosing for CrCl 30-50?

50 mg once a day

56
New cards

sitagliptin dosing for CrCl < 30?

25 mg once daily

57
New cards

saxagliptin dosing for CrCl <= 50

2.5 mg once daily

58
New cards

renal adjustments for linagliptin

no adjustments necessary

59
New cards

what are the risks associated with DPP-4 inhibitors in patients with renal dysfunction?

increased risk of hypoglycemia and pancreatitis

60
New cards

what CrCl should you avoid diuretic use in?

CrCl < 30 ml/min

61
New cards

renal adjustments for diuretics if CrCl is 25-50 ml/min?

~2x normal dose

62
New cards

renal adjustments for diuretics if CrCl is < 25 ml/min?

~4x normal dose

63
New cards

T/F: NSAIDs should be avoided in non-dialysis CKD?

true

64
New cards

why should NSAIDs be used cautiously in kidney failure?

increased risk of GI bleed and increased risk of CV events

65
New cards

what is the preferred analgesic in kidney disease patients?

acetaminophen <3333333

66
New cards

when to avoid duloxetine

CrCl < 30 ml/min (exposure ~ 2 fold higher)

67
New cards

renal dosing for tricyclic antidepressants

no renal dosing, may cause altered mental status

68
New cards

renal dosing for anticonvulsants

no kidney dosing but drug interactions and side effect potential

69
New cards

renal dysfunction effect on gabapentin/pregabalin

increased risk of falls and altered mentation